Plain-language overview
An extracellular-vesicle preparation can contain much more than EVs. Proteins, lipid particles, fragments from damaged cells, particles from culture media, serum EVs, viruses, and processing chemicals can remain in the preparation.
This matters because contaminants can change particle counts, laboratory measurements, and even biological effects. A signal attributed to EVs may actually come partly or entirely from non-EV material.
Purity therefore cannot be established by particle size, particle number, or a few positive EV markers. Researchers need to look directly for the contaminants that are plausible for the source material and manufacturing process.
Protein aggregates
Protein aggregates are clusters of proteins that are not extracellular vesicles but can behave like EVs in some laboratory methods.
They can form because of cell death, high protein concentrations, freezing and thawing, agitation, changes in acidity, or processing. Some aggregates can be counted as particles or can bind fluorescent dyes and antibodies.
If protein aggregates are not recognized, researchers may overestimate EV concentration or incorrectly attribute a biological effect to EVs.
Figure 1 placeholder — Protein aggregates
Lipoproteins
Lipoproteins transport fats through blood and other biological fluids. They are especially important contaminants when EVs are isolated from plasma or serum.
A chylomicron, very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein can overlap EVs in size, density, or other physical properties. As a result, they can be collected along with EVs during several common separation methods.
Because lipoproteins carry large amounts of protein and lipid and can associate with nucleic acids, contamination can substantially distort measurements of EV composition.
Figure 2 placeholder — Lipoproteins
Cell debris
Cell debris is material released from damaged, dying, or mechanically disrupted cells. It can include a membrane fragment, organelle fragment, cytoskeletal material, and apoptotic material.
Clarification steps are used early in processing to remove cells and larger debris, but some material can remain. Cell health, harvesting technique, processing delay, centrifugation, and filtration all affect the amount of debris.
Debris can contain proteins, RNA, DNA, lipids, and enzymes. Without appropriate controls, these materials can be mistaken for EV cargo or EV biological activity.
Figure 3 placeholder — Cell debris
Media-derived particles
Media-derived particles come from the materials used to grow cells rather than from the intended producer cells themselves.
Culture supplements, proteins, lipid particles, growth-factor formulations, and other media components can enter the same separation process used to collect EVs.
A media-only control can be processed through the complete EV workflow to help identify background caused by the culture medium, reagents, equipment, or processing steps.
Figure 4 placeholder — Media-derived particles
Serum-derived EVs
Serum-derived EVs are extracellular vesicles naturally present in animal serum used as a culture supplement. Fetal bovine serum is a common example.
EV-depleted serum can reduce this background but may not eliminate it completely. The depletion process can also change the composition of the serum and potentially change how the cultured cells behave.
Serum-free or chemically defined media can reduce some serum-related confounding, but these conditions have their own biological and manufacturing effects. The culture conditions therefore need to be clearly documented.
Figure 5 placeholder — Serum-derived EVs
Viruses
Viruses and a virus-like particle can share important physical features with extracellular vesicles, including size, density, membrane structure, and aspects of how they are formed.
In some biological systems, separating viral particles from EVs can be particularly difficult. Size or appearance alone is not enough to distinguish them.
An adventitious virus is an unintended viral contaminant. Appropriate source-cell testing, raw-material controls, and an adventitious-agent testing strategy are important parts of product safety.
Figure 6 placeholder — Viruses
Residual processing materials
Residual processing materials are substances introduced during manufacturing that remain after the process is complete.
Examples can include polyethylene glycol used for precipitation, density-gradient medium, detergents, enzymes, affinity reagents, buffer components, antibiotics, cryoprotectants, or materials released from manufacturing equipment.
An extractable or leachable from tubing, filters, containers, or other materials can also enter a product. Residual substances can interfere with laboratory tests or create safety concerns, so relevant limits and testing methods should be defined.
Figure 7 placeholder — Residual processing materials
Purity depends on what you are looking for
A preparation may contain very little of one contaminant but substantial amounts of another. Saying that an EV preparation is simply 'pure' can therefore be misleading without explaining what was measured.
EV purity is best understood as a multidimensional assessment of the intended vesicles together with the unwanted material that remains.
Controls help identify background
A process blank can be carried through processing without the intended biological sample to help identify material introduced by reagents, equipment, or the workflow itself.
A media-only control can similarly help determine which particles or molecular signals originate from the cell-culture medium rather than the producer cells.
Particle-to-protein ratio
A particle-to-protein ratio has sometimes been used as a rough indicator of EV preparation purity.
It is not a universal purity measurement. Particle counts can include non-EV particles, and bulk protein measurements can include both EV-associated and contaminating proteins.
Why contaminants matter in functional studies
A biological effect seen after applying an EV preparation to cells or animals does not automatically prove that EVs caused the effect.
Soluble proteins, lipoproteins, cytokines, viruses, residual processing chemicals, or other co-isolated material may contribute. Functional studies therefore need controls that help separate EV-dependent effects from non-EV effects.
Questions patients should ask
What contaminants were tested in the EV product? Were proteins, lipoproteins, cell debris, media-derived particles, serum EVs, viruses, and processing residuals considered? Were media-only controls or process blanks used? What purity specifications must each manufacturing lot meet? Does the evidence show that the claimed biological activity comes from EVs rather than co-isolated material?
Bottom line
EV purity is not established by a high particle count, a particular size range, or a few EV-associated proteins.
Strong evidence directly evaluates relevant contaminants, uses process-matched controls, and avoids attributing molecular or biological signals to EVs until reasonable non-EV explanations have been addressed.
How this review was prepared
This Patient Edition was derived directly from the explicitly approved 0609 Professional Edition and preserves the same seven controlling Points.